PortfoliosLab logoPortfoliosLab logo
ISIN
US00760J1088
CUSIP
00760J108
IPO Date
Aug 14, 1997

Highlights

Market Cap
$3.14B
Enterprise Value
$3.12B
EPS (TTM)
-$0.38
Total Revenue (TTM)
$45.26M
Gross Profit (TTM)
$13.90M
EBITDA (TTM)
-$13.56M
Year Range
$11.76 - $126.62
Target Price
$25.00
ROA (TTM)
-7.27%
ROE (TTM)
-8.23%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

AEHR Performance Chart

Aehr Test Systems (AEHR) is up 407.1% since the beginning of the year. At $102 per share, AEHR is trading 19.1% below its 52-week high of $127. Investors who bought $1,000 worth of AEHR shares 5 years ago would now be looking at an investment worth $38,347.


Loading charts...

S&P 500 Index

Returns By Period

Aehr Test Systems (AEHR) has returned 407.13% so far this year and 810.13% over the past 12 months. Looking at the last ten years, AEHR has achieved an annualized return of 50.48%, outperforming the S&P 500 Index benchmark, which averaged 13.71% per year.


Aehr Test Systems

1D
-9.65%
1M
7.76%
YTD
407.13%
6M
349.67%
1Y
810.13%
3Y*
36.85%
5Y*
107.37%
10Y*
50.48%

Benchmark (S&P 500 Index)

1D
-1.44%
1M
-1.45%
YTD
7.60%
6M
6.59%
1Y
22.24%
3Y*
19.20%
5Y*
11.54%
10Y*
13.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AEHR Monthly Returns History

Based on dividend-adjusted daily data since Aug 15, 1997, AEHR's average daily return is +0.17%, while the average monthly return is +3.05%. At this rate, an investment would double in approximately 1.9 years.

Historically, 46% of months were positive and 54% were negative. The best month was Apr 2026 with a return of +144.2%, while the worst month was Oct 2023 at -48.5%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.

On a daily basis, AEHR closed higher 42% of trading days. The best single day was Jul 19, 2021 with a return of +87.9%, while the worst single day was Jul 23, 2008 at -29.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202626.99%45.98%-0.94%144.23%1.95%10.90%407.13%
2025-31.87%-14.92%-24.38%17.01%11.84%35.53%30.70%47.63%20.68%-13.68%-11.62%-12.10%21.41%
2024-44.03%9.56%-23.79%-3.39%-3.92%-2.95%68.93%-19.40%-15.52%9.57%-15.55%39.87%-37.32%
202373.93%-4.61%-6.99%-20.21%33.41%24.92%26.45%-2.20%-10.41%-48.45%-2.55%15.55%31.99%
2022-47.27%6.67%-25.29%-24.41%9.11%-10.50%52.13%27.43%-3.03%45.89%26.74%-22.90%-16.87%
2021-9.49%22.27%-10.00%-10.32%-0.44%22.67%103.62%32.74%82.98%65.71%-22.99%38.81%855.73%

Benchmark Metrics

Aehr Test Systems has an annualized alpha of 41.49%, beta of 0.96, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since August 15, 1997.

  • This stock captured 130.41% of S&P 500 Index gains and 126.44% of its losses - amplifying both gains and losses, but participating more in upside than downside.
  • R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
41.49%
Beta
0.96
0.04
Upside Capture
130.41%
Downside Capture
126.44%

Return for Risk

Risk / Return Rank

AEHR ranks 98 for risk / return — in the top 98% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


AEHR Risk / Return Rank: 9898
Overall Rank
AEHR Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
AEHR Sortino Ratio Rank: 9696
Sortino Ratio Rank
AEHR Omega Ratio Rank: 9494
Omega Ratio Rank
AEHR Calmar Ratio Rank: 9999
Calmar Ratio Rank
AEHR Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Aehr Test Systems (AEHR) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AEHRBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

+5.06

Sortino ratioReturn per unit of downside risk

+1.94

Omega ratioGain probability vs. loss probability

1.51

1.32

+0.19

Calmar ratioReturn relative to maximum drawdown

19.34

2.46

+16.88

Martin ratioReturn relative to average drawdown

43.44

10.92

+32.52

Dividends

Dividend History


Aehr Test Systems doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Aehr Test Systems. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aehr Test Systems was 97.98%, occurring on Nov 22, 2011. Recovery took 2503 trading sessions.

The current Aehr Test Systems drawdown is 12.17%.


Related event

Drawdown

Fall

Recovery

Underwater

2011 bear market2011
-97.98%Nov 2011
14y 2mo9y 11mo
24y 1moSep 1997 - Nov 2021
2025 selloff2025
-87.37%Apr 2025
1y 8mo1y
2y 8moAug 2023 - Apr 2026
Bear market2022
-73.02%Jul 2022
7mo 25d4mo 25d
1y 15dNov 2021 - Nov 2022
2023 bear market2023
-39.77%Apr 2023
1mo 3d1mo 7d
2mo 10dMar 2023 - Jun 2023
2023 bear market2023
-36.27%Jan 2023
1mo 4d5d
1mo 9dDec 2022 - Jan 2023

Drawdown Indicators


AEHRBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-97.98%

-56.78%

-41.20%

Max Drawdown (1Y)

Largest decline over 1 year

-42.31%

-9.10%

-33.21%

Max Drawdown (3Y)

Largest decline over 3 years

-87.37%

-18.90%

-68.47%

Max Drawdown (5Y)

Largest decline over 5 years

-87.37%

-25.43%

-61.94%

Max Drawdown (10Y)

Largest decline over 10 years

-87.37%

-33.92%

-53.45%

Current Drawdown

Current decline from peak

-12.17%

-3.21%

-8.96%

Average Drawdown

Average peak-to-trough decline

-79.53%

-10.71%

-68.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.80%

2.04%

+16.76%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aehr Test Systems over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Aehr Test Systems is priced in the market compared to other companies in the Semiconductor Equipment & Materials industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AEHR relative to other companies in the Semiconductor Equipment & Materials industry. Currently, AEHR has a P/S ratio of 68.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AEHR in comparison with other companies in the Semiconductor Equipment & Materials industry. Currently, AEHR has a P/B value of 22.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with AEHR

Add Aehr Test Systems to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with AEHR